1. Market Research
  2. > Therapy Market Trends
  3. > Antimalarials Industry

Antimalarials Industry Statistics

You might be interested in: Malaria, Infectious Disease, Hospital, Pharmaceutical, HIV AIDS, Therapy, Anti-Infective, Vaccine, HIV Antiviral, Antiviral, Opioid, Monoclonal Antibody, Chemotherapy, Hormone, Targeted Therapy, Analgesic, Hepatitis Treatment, Antidiabetics, Cardiovascular Drug, Antipsychotic.

1-7 of about 100 reports for Antimalarials

Global Antimalarials and Anti-Infective Market - Forecast

  • April 2017
    11 pages
  • Antimalarials  

    Anti-Infective  

    Therapy  

  • Africa  

    World  

View report >

Antimalarials Market

  • January 2017
    21 pages
  • Antimalarials  

  • Africa  

    Nigeria  

View report >

Therapy and Antimalarials Market in Europe

  • July 2017
    29 pages
  • Therapy  

    Antimalarials  

    Antihypertensiv...  

  • Europe  

View report >

Gastric Cancer Statistics and Antimalarials Market in China

  • November 2017
    6 pages
  • Gastric Cancer  

    Antimalarials  

    Cancer Immunoth...  

  • China  

View report >

Antimalarials and Therapy Market in the UK

  • January 2017
    12 pages
  • Antimalarials  

    Therapy  

    Anti-Infective  

  • United Kingdom  

View report >

Antimalarials and Anti-Infective Market in India

  • January 2017
    11 pages
  • Antimalarials  

    Pharmacy  

    Tuberculosis  

  • India  

    United Kingdom  

View report >

Antimalarials and Opioid Market in Australia

  • January 2018
    71 pages
  • Antimalarials  

    Opioid  

    Psychoactive Dr...  

  • Australia  

View report >
About 100 reports for Antimalarials

Purchase Reports From Reputable Market Research Publishers
(From $ 127 - $ 10995)

Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends

Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends

  • $ 2714
  • Industry report
  • January 2018
  • by La Merie Publishing

Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trendsIt is estimated that ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on